Skip to main content
PMC home page
The AAPS Journal logoLink to The AAPS Journal
. 2004 Sep 1;6(3):1–6. doi: 10.1208/aapsj060317

Formulation design of double-layer in the outer shell of dry-coated tablet to modulate lag time and time-controlled dissolution function: Studies on micronized ethylcellulose for dosage form design (VII)

Shan-Yang Lin 1,✉, Kung-Hsu Lin 1, Mei-Jane Li 1
PMCID: PMC2751242  PMID: 15760102

Abstract

The dry-coated tablet with optimal lag time was designed to simulate the dosing time of drug administration according to the physiological needs. Different compositions of ethylcellulose (EC) powder with a coarse particle (167.5 μm) and several fine particles (<6 μm), respectively, were mixed to formulate the whole layer of the outer shell of dry-coated tablets. The formulations containing different weight ratios of coarse/fine particles of EC powders or 167.5 μm EC powder/excipient in the upper layer of the outer shell to influence the release behavior of sodium diclofenac from dry-coated tablet were also explored. The results indicate that sodium diclofenac released from all the dry-coated tablets exhibited an initial lag period, followed by a stage of rapid drug release. When the mixture of the coarse/fine particles of EC powders was incorporated into the whole layer, the lag time was almost the same. The outer shell broke into 2 halves to make a rapid drug release after the lag time, which belonged to the time-controlled disruption of release mechanism. When the lower layer in the outer shell was composed of 167.5 μm EC powder and the upper layer was formulated by mixing different weight ratios of 167.5 μm and 6 μm of EC powders, the drug release also exhibited a time-controlled disruption behavior. Its lag time might be freely modulated, depending on the amount of 6 μm EC powder added. Once different excipients were respectively incorporated into the upper layer of the outer shell, different release mechanisms were observed as follows: time-controlled explosion for Explotab, disruption for Avicel and spray-dried lactose, erosion for dibasic calcium phosphate anhydrate, and sigmoidal profile for hydroxypropyl methylcellulose.

Keywords: micronized ethylcellulose, dry-coated tablet, outer layer, time-controlled dissolution, lag time

Full Text

The Full Text of this article is available as a PDF (183.6 KB).

References

  • 1.Smolensky MH, Reinberg AE, Martin RJ, Haus E. Clinical chronobiology and chronotherapentics with applications to asthma. Chronobiol Int. 1999;16:539–563. doi: 10.3109/07420529908998728. [DOI] [PubMed] [Google Scholar]
  • 2.Berner B, John VA. Pharmacokinetic characterisation of transdermal delivery systems. Clin Pharmacokinet. 1994;26:121–134. doi: 10.2165/00003088-199426020-00005. [DOI] [PubMed] [Google Scholar]
  • 3.Smith DH, Neutel JM, Weber MA. A new chronotherapeutic oral drug absorption system for verapamil optimizes blood pressure control in the morning. Am J Hypertens. 2001;14:14–19. doi: 10.1016/S0895-7061(00)01227-9. [DOI] [PubMed] [Google Scholar]
  • 4.Brayden DJ. Controlled release technologies for drug delivery. Drug Discov Today. 2003;8:976–978. doi: 10.1016/S1359-6446(03)02874-5. [DOI] [PubMed] [Google Scholar]
  • 5.Paolisso G, Scheen AJ, Giugliano D, et al. Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: importance of pulse frequency. J Clin Endocrinol Metab. 1991;72:607–615. doi: 10.1210/jcem-72-3-607. [DOI] [PubMed] [Google Scholar]
  • 6.Glasser SP, Neutel JM, Gana TJ, Albert KS. Efficacy and safety of a once daily graded-release diltiazem formulation in essential hypertension. Am J Hypertens. 2003;16:51–58. doi: 10.1016/S0895-7061(02)03153-9. [DOI] [PubMed] [Google Scholar]
  • 7.Sica D, Frishman WH, Manowitz N. Pharmacokinetics of propranolol after single and multiple dosing with sustained release propranolol or propranolol CR (innopran XL), a new chronotherapeutic formulation. Heart Dis. 2003;5:176–181. doi: 10.1097/01.HDX.0000074436.09658.3b. [DOI] [PubMed] [Google Scholar]
  • 8.Takeuchi H, Yasuji T, Yamamoto H, Kawashima Y. Spray-dried lactose composite particles containing an ion complex of alginate-chitosan for designing a dry-coated tablet having a time-controlled releasing function. Pharm Res. 2000;17:94–99. doi: 10.1023/A:1007530927887. [DOI] [PubMed] [Google Scholar]
  • 9.Gonzalez-Rodriguez ML, Maestrelli F, Mura P, Rabasco AM. In vitro release of sodium diclofenac from a central core matrix tablet aimed for colonic drug delivery. Eur J Pharm Sci. 2003;20:125–131. doi: 10.1016/S0928-0987(03)00181-7. [DOI] [PubMed] [Google Scholar]
  • 10.Lin SY, Lin KH, Li MJ. Micronized ethylcellulose used for designing a directly compressed time-controlled disintegration tablet. J Control Release. 2001;70:321–328. doi: 10.1016/S0168-3659(00)00360-6. [DOI] [PubMed] [Google Scholar]
  • 11.Lin KH, Lin SY, Li MJ. Compression forces and amount of outer coating layer affecting the time-controlled disintegration of the compression-coated tablets prepared by direct compression with micronized ethylcellulose. J Pharm Sci. 2001;90:2005–2009. doi: 10.1002/jps.1151. [DOI] [PubMed] [Google Scholar]
  • 12.Lin SY, Lin KH, Li MJ. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets. J Pharm Sci. 2002;91:2040–2046. doi: 10.1002/jps.10197. [DOI] [PubMed] [Google Scholar]
  • 13.Lin SY, Lin KH. Compression behavior of the different grades of ethylcellulose. J Pharm Sci Technol Japan. 1995;55:254–260. [Google Scholar]
  • 14.Lin SY, Lin KH. Water uptake and drug release behavior of drugloaded compacts prepared from different grades of ethylcellulose. Eur J Pharm Biopharm. 1996;42:193–198. [Google Scholar]
  • 15.Staniforth JN. Relationship between particle packing and the physical stability of powder mixes. J Pharm Pharmacol. 1985;37:692–697. doi: 10.1111/j.2042-7158.1985.tb04944.x. [DOI] [PubMed] [Google Scholar]
  • 16.Ishino R, Yoshino H, Hirikawa Y, Noda K. Influence of internal structure on kinetics of drug release from wax matrix tablets. Chem Pharm Bull (Tokyo) 1990;38:3440–3445. doi: 10.1248/cpb.38.3440. [DOI] [PubMed] [Google Scholar]
  • 17.Shah U, Augsburger L. Multiple sources of sodium starch glycolate, NF: evaluation of functional equivalence and development of standard performance tests. Pharm Dev Technol. 2002;7:345–359. doi: 10.1081/PDT-120005731. [DOI] [PubMed] [Google Scholar]
  • 18.Kachrimanis K, Nikolakakis I, Malamataris S. Tensile strength and disintegration of tableted silicified microcrystalline cellulose: influences of interparticle bonding. J Pharm Sci. 2003;92:1489–1501. doi: 10.1002/jps.10403. [DOI] [PubMed] [Google Scholar]
  • 19.Li JZ, Rekhi GS, Augsburger LL, Shangraw RF. The role of intra- and extragranular microcrystalline cellulose in tablet dissolution. Pharm Dev Technol. 1996;1:343–355. doi: 10.3109/10837459609031429. [DOI] [PubMed] [Google Scholar]
  • 20.Vervarcke S, Ollevier F, Kinget R, Michoel A. Development of a lag time coating for drug-layered fish feed pellets. Pharm Dev Technol. 2002;7:471–480. doi: 10.1081/PDT-120015049. [DOI] [PubMed] [Google Scholar]
  • 21.Lin SY, Cheng CL, Lin PC. Preparation and evaluation of sodium diclofenac controlled-release tablets. II. Dibasic calcium phosphate as a retardant in mixtures for direct compression. Pharm World Sci. 1995;17:42–47. doi: 10.1007/BF01875053. [DOI] [PubMed] [Google Scholar]
  • 22.Zhang YE, Schwartz JB. Effect of diluents on tablet integrity and controlled drug release. Drug Dev Ind Pharm. 2000;26:761–765. doi: 10.1081/DDC-100101295. [DOI] [PubMed] [Google Scholar]

Articles from The AAPS Journal are provided here courtesy of American Association of Pharmaceutical Scientists

RESOURCES